Teva Pharmaceuticals recalls Octreotide Acetate Injection 10:00 mcg/mL vials due to lack of assurance of sterility. This may cause infections. Affected lots: 31327466B, exp. 08/2021.
Lack of Assurance of Sterility
Teva Pharmaceuticals is recalling Octreotide Acetate Injection 100 mcg/mL vials because they may not be sterile. This could lead to infections in patients using the medication.
The vials may not be sterile, which could lead to infections if the medication is injected. This is a risk for patients receiving the injection.
Patients prescribed this medication by a doctor are affected. Those using the product without medical supervision are not at risk.
Check for the product name 'Octreotide Acetate Injection 100 mcg/mL, 1 mL single-dose vial'. Look for lot number 31327466B and expiration date 08/2021.
Verify the lot number and expiration date on the vial label.
The product may not be sterile, which could cause infections. Do not use if you have the lot number 31327466B.
Check the lot number and expiration date. If it matches 31327466B with expiration 08/2021, stop using it.
The recall does not specify a replacement process. Contact your doctor for guidance.
We’ve drafted a message you can send Teva to request your refund or repair — edit it as you like.
Subject: Recall D-0744-2021 — Teva Teva Hello, I own a Teva that is covered by recall D-0744-2021 from Teva. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
